Novavax soars 13% after inking deal with UK for 60 million doses of coronavirus vaccine
rallied as much as 13.3% on Friday after reaching a deal with the UK for 60 million doses of its coronavirus vaccine.
The biotech company did not reveal how much the government paid for the potential vaccine. Novavax will partner with the UK government for phase 3 trials of its NVX-CoV2373 vaccine, according to a. The study will involve roughly 9,000 adults in the UK aged between 18 and 85 and is set to begin in the third quarter of 2020.
"We believe that Novavax has a highly innovative vaccine that could be the first in its class of protein-based vaccine options," Kate Bingham, chair of the UK government's Vaccines Taskforce, said in a statement, adding that Novavax's recent clinical data is"encouraging."The deal calls for Novavax to begin supplying the 60 million doses as early as the first quarter of 2021.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Novavax Inks Covid-19 Vaccine Deal With U.K. for 60 Million DosesNovavax said it has struck a deal to provide 60 million doses of its Covid-19 vaccine to the U.K. for an undisclosed sum and receive funding to support a late-stage trial in the country
Weiterlesen »
Novavax to deliver 60 million doses of COVID-19 vaccine candidate to UK for trialU.S. drug developer Novavax Inc said on Friday the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373, for a phase 3 clinical trial in the country.
Weiterlesen »
Novavax to deliver 60 million doses of COVID-19 vaccine candidate to UKU.S. drug developer Novavax Inc said on Friday the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373.
Weiterlesen »
Novavax shares rise after deal to provide 60 million doses of coronavirus vaccine to U.K.Novavax shares rose after the company said it reached a deal with the U.K. to supply 60 million doses of its potential coronavirus vaccine.
Weiterlesen »
UK buys more potential COVID-19 vaccines from J&J and NovavaxBritain will buy potential COVID-19 vaccines from U.S. drugmakers Johnson & Johnson and Novavax Inc, the companies said on Friday, bringing the total number of deals by the UK government to six as the race for shots heats up.
Weiterlesen »
UK government secures early access to 90 million doses of two 'promising' vaccine candidatesThe British government has secured 90 million doses of two vaccine candidates still in clinical trials, the Department for Business, Energy & Industrial Strategy says.
Weiterlesen »